FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP) Stock News

USA - Nasdaq - NASDAQ:FBIOP - US34960Q2084

7.7079 USD

+0.01 (+0.1%)

Last: 12/12/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

FBIOP Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

2 months ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout

2 months ago - By: Benzinga - Mentions: DH HCTI FBIO LRMR ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

2 months ago - By: Benzinga - Mentions: SI ENTA DBVT INTS ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

2 months ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing

2 months ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101

3 months ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference

4 months ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

7 months ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

7 months ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

7 months ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference

9 months ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights

9 months ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform

a year ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT

a year ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease

a year ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

a year ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech to Participate in October 2024 Investor Conferences

a year ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements

a year ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

a year ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

a year ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027

a year ago - By: Fortress Biotech, Inc. - Mentions: FBIO

Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock